Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-4.34	297.71	311.20
Graham Fair Price	107.23	95630.70	46146.22
PEG	-93.10	0.02	-0.23
Price/Book	17.55	0.46	0.39
Price/Cash Flow	-74.47	17.18	-67.28
Prices/Earnings	-67.74	6.26	19.40
Price/Sales	-32.18	1.12	1.66
Price/FCF	-74.47	17.18	-67.28
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-33.79	1.00	1.51
Operating Margin	-33.79	1.00	1.51
ROA	292.17	< 0.005	< 0.005
ROE	< 0.005	0.02	264.42
ROIC	0.07	0.07	-9.72
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.16	0.04	298.63
Dividends QOQ	< 0.005	-1.00	12491.78
EBIT QOQ	8.52	0.26	-96.91
EPS QOQ	-0.84	3.91	367.45
FCF QOQ	-1.08	6.07	463.54
Revenue QOQ	1.69	0.91	-46.10
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-34.23	0.00	inf
Days Sales Outstanding (DSO)	106.23	1.06	-99.00
Inventory Turnover	-2.63	0.00	inf
Debt/Capitalization	0.74	0.78	6.57
Quick Ratio	0.46	0.45	-2.56
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	137052.97	148780.51	8.56
Cash	299171.92	303395.43	1.41
Capex	-534.52	-302.31	43.44
Free Cash Flow	-796.69	3981.71	399.78
Revenue	32317.44	60809.01	88.16
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.19	0.45	140.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	264.03	231.26	-12.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating